Global In Situ Hybridization (ISH) Industry

Global In Situ Hybridization (ISH) Industry

  • October 2022 •
  • 504 pages •
  • Report ID: 6232859 •
  • Format: PDF
Abstract:

What’s New for 2022??

Global competitiveness and key competitor percentage market shares

Market presence across multiple geographies - Strong/Active/Niche/Trivial

Online interactive peer-to-peer collaborative bespoke updates

Access to our digital archives and MarketGlass Research Platform

Complimentary updates for one yearGlobal In Situ Hybridization (ISH) Market to Reach $1.3 Billion by 2027
- In the changed post COVID-19 business landscape, the global market for In Situ Hybridization (ISH) estimated at US$846.6 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 5.8% over the period 2020-2027. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$885.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chromogenic In Situ Hybridization (cish) segment is readjusted to a revised 6.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $351.6 Million, While China is Forecast to Grow at 7.1% CAGR
- The In Situ Hybridization (ISH) market in the U.S. is estimated at US$351.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$85.7 Million by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Select Competitors (Total 38 Featured)
Abbott Laboratories
Abnova Corporation
Advanced Cell Diagnostics, Inc.
Agilent Technologies Inc
Bio SB
Biocare Medical, LLC
BioGenex Laboratories
Bio-Techne Corporation
Genemed Biotechnologies, Inc.
Leica Biosystems Nussloch GmbH
Thermo Fisher Scientific
Merck KGaA
Oxford Gene Technologies
PerkinElmer Inc.